Journal Logo

Poster Session II: Myelodysplastic syndromes – Clinical

PS1337 IVOSIDENIB (AG-120) INDUCES DURABLE REMISSIONS AND TRANSFUSION INDEPENDENCE IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME IN A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

Foran, J.M.1; DiNardo, C.D.2; Watts, J.M.3; Stein, E.M.4; de Botton, S.5; Fathi, A.T.6; Prince, G.T.7; Stein, A.S.8; Stone, R.M.9; Patel, P.A.10; Tallman, M.S.4; Choe, S.11; Wang, H.11; Zhang, V.11; Dai, D.11; Fan, B.11; Yen, K.E.11; Kapsalis, S.M.11; Hickman, D.11; Agresta, S.V.11; Liu, H.11; Wu, B.11; Attar, E.C.11; Kantarjian, H.M.2

Author Information
doi: 10.1097/01.HS9.0000563628.38037.c3
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.